Accordingly, only a fraction of CRIS-A samples had a high L score, and this class received additional samples from CMS3, encompassing tumours with mixed MSI status, enrichment for KRAS mutations, and metabolic deregulation, but devoid of intense leukocyte infiltration. The gene discussed is KRAS; the disease is neoplasm.